Clinical trial
Neuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America
NCT07192991 is registered in ClinicalTrials.gov with Latin American Cooperative Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neuroendocrine Carcinomas: Patient Journey And Treatment Outcomes In Latin America
- Lead sponsor
- Latin American Cooperative Oncology Group
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 16, 2025
- Completion date
- September 30, 2026
- Enrollment
- 200 (estimated)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.
lung neuroendocrine carcinoma, neuroendocrine carcinomas